更正：基于CRISPR的抗菌剂以对抗抗生素耐药菌和病原菌。
Correction: CRISPR-based antimicrobials to obstruct antibiotic-resistant and pathogenic bacteria.
作者信息
Araya Dennise Palacios, Palmer Kelli L, Duerkop Breck A
出版信息
PLoS Pathog. 2021 Dec 13;17(12):e1010153. doi: 10.1371/journal.ppat.1010153. eCollection 2021 Dec.
Abstract
[This corrects the article DOI: 10.1371/journal.ppat.1009672.].
摘要
[本文更正了文章的数字对象标识符：10.1371/journal.ppat.1009672。]
相似文献
1
Correction: CRISPR-based antimicrobials to obstruct antibiotic-resistant and pathogenic bacteria.更正：基于CRISPR的抗菌剂以对抗抗生素耐药菌和病原菌。
PLoS Pathog. 2021 Dec 13;17(12):e1010153. doi: 10.1371/journal.ppat.1010153. eCollection 2021 Dec.
2
CRISPR-based antimicrobials to obstruct antibiotic-resistant and pathogenic bacteria.基于CRISPR的抗菌剂用于对抗抗生素耐药性和致病性细菌。
PLoS Pathog. 2021 Jul 8;17(7):e1009672. doi: 10.1371/journal.ppat.1009672. eCollection 2021 Jul.
3
Correction: HIV Reactivation from Latency after Treatment Interruption Occurs on Average Every 5-8 Days-Implications for HIV Remission.更正：治疗中断后潜伏的HIV平均每5 - 8天重新激活一次——对HIV缓解的影响
PLoS Pathog. 2016 Aug 25;12(8):e1005745. doi: 10.1371/journal.ppat.1005745. eCollection 2016 Aug.
4
Correction: Effects of chronic exposure to arsenic on the fecal carriage of antibiotic-resistant Escherichia coli among people in rural Bangladesh.更正：长期接触砷对孟加拉国农村地区人群粪便中耐抗生素大肠杆菌携带情况的影响。
PLoS Pathog. 2023 Sep 29;19(9):e1011690. doi: 10.1371/journal.ppat.1011690. eCollection 2023 Sep.
5
Correction: TnSeq of Mycobacterium tuberculosis clinical isolates reveals strain-specific antibiotic liabilities.更正：结核分枝杆菌临床分离株的TnSeq揭示了菌株特异性抗生素易感性。
PLoS Pathog. 2019 Jun 4;15(6):e1007846. doi: 10.1371/journal.ppat.1007846. eCollection 2019 Jun.
6
Correction: On the relationship between Pathogenic Potential and Infective Inoculum.更正：关于致病潜力与感染接种量之间的关系。
PLoS Pathog. 2023 Feb 23;19(2):e1011191. doi: 10.1371/journal.ppat.1011191. eCollection 2023 Feb.
7
Correction: Oxidation of Helix-3 Methionines Precedes the Formation of PK Resistant PrPSc.更正：螺旋3甲硫氨酸的氧化先于抗蛋白酶K的朊病毒蛋白（PrPSc）形成。
PLoS Pathog. 2017 May 3;13(5):e1006293. doi: 10.1371/journal.ppat.1006293. eCollection 2017 May.
8
Correction: Emergence of Prions Selectively Resistant to Combination Drug Therapy.更正：出现对联合药物疗法具有选择性抗性的朊病毒。
PLoS Pathog. 2024 Jan 8;20(1):e1011919. doi: 10.1371/journal.ppat.1011919. eCollection 2024 Jan.
9
Correction: Type I IFNs facilitate innate immune control of the opportunistic bacteria Burkholderia cenocepacia in the macrophage cytosol.更正：I型干扰素促进巨噬细胞胞质溶胶中对机会致病菌洋葱伯克霍尔德菌的先天性免疫控制。
PLoS Pathog. 2021 Aug 4;17(8):e1009821. doi: 10.1371/journal.ppat.1009821. eCollection 2021 Aug.
10
Correction: Correction: Correction: Influenza Virus Targets Class I MHC-Educated NK Cells for Immunoevasion.更正：更正：更正：流感病毒靶向经I类主要组织相容性复合体（MHC）教育的自然杀伤（NK）细胞以实现免疫逃逸。
PLoS Pathog. 2017 Feb 15;13(2):e1006210. doi: 10.1371/journal.ppat.1006210. eCollection 2017 Feb.
引用本文的文献
1
Role of CRISPR-Cas systems and anti-CRISPR proteins in bacterial antibiotic resistance.CRISPR-Cas系统和抗CRISPR蛋白在细菌抗生素耐药性中的作用。
Heliyon. 2024 Jul 16;10(14):e34692. doi: 10.1016/j.heliyon.2024.e34692. eCollection 2024 Jul 30.
2
Beyond antibiotics: CRISPR/Cas9 triumph over biofilm-associated antibiotic resistance infections.超越抗生素：CRISPR/Cas9 战胜生物膜相关抗生素耐药性感染。
Front Cell Infect Microbiol. 2024 Jul 5;14:1408569. doi: 10.3389/fcimb.2024.1408569. eCollection 2024.
3
Recent advances in gene-editing approaches for tackling antibiotic resistance threats: a review.基因编辑方法在应对抗生素耐药性威胁方面的最新进展：综述。
Front Cell Infect Microbiol. 2024 Jun 26;14:1410115. doi: 10.3389/fcimb.2024.1410115. eCollection 2024.
4
Aminoglycoside uptake, stress, and potentiation in Gram-negative bacteria: new therapies with old molecules.氨基糖苷类抗生素在革兰氏阴性菌中的摄取、应激和增效作用：老分子的新疗法。
Microbiol Mol Biol Rev. 2023 Dec 20;87(4):e0003622. doi: 10.1128/mmbr.00036-22. Epub 2023 Dec 4.
5
Enterococcus faecalis Strains with Compromised CRISPR-Cas Defense Emerge under Antibiotic Selection for a CRISPR-Targeted Plasmid.在针对 CRISPR 靶向质粒的抗生素选择下，出现了 CRISPR-Cas 防御功能受损的粪肠球菌菌株。
Appl Environ Microbiol. 2023 Jun 28;89(6):e0012423. doi: 10.1128/aem.00124-23. Epub 2023 Jun 6.
本文引用的文献
1
CRISPR-based antimicrobials to obstruct antibiotic-resistant and pathogenic bacteria.基于CRISPR的抗菌剂用于对抗抗生素耐药性和致病性细菌。
PLoS Pathog. 2021 Jul 8;17(7):e1009672. doi: 10.1371/journal.ppat.1009672. eCollection 2021 Jul.
Zotero 插件